Related Experiment Videos
Hormone replacement therapy with tibolone: effects on sexual functioning in postmenopausal women
Christian Egarter1, AtaM Topcuoglu, Sonja Vogl
1Department of Obstetrics and Gynecology, University of Vienna, Vienna, Austria. christian.egarter@akh-wien.ac.at
Acta Obstetricia Et Gynecologica Scandinavica
|August 23, 2002
Summary
Tibolone significantly improved sexual satisfaction and libido in postmenopausal women. This hormone replacement therapy offers benefits for women experiencing sexual changes during menopause.
Area of Science:
- Reproductive Endocrinology
- Women's Health
- Pharmacology
Background:
- Hormonal fluctuations during menopause can negatively impact sexual well-being and libido.
- Postmenopausal women often experience sexual dysfunction, necessitating effective treatment options.
Purpose of the Study:
- To evaluate the efficacy of tibolone (Liviel(R)) in enhancing the sexual lives of postmenopausal women.
- To assess the impact of tibolone on various facets of libido and sexual satisfaction.
Main Methods:
- An open-label, multicenter study involving first-time hormone replacement therapy (HRT) users.
- Participants received tibolone 2.5 mg daily for a minimum of four months.
- Subjective sexual experiences were assessed using validated questionnaires at baseline and after treatment.
Main Results:
- A total of 184 postmenopausal women were enrolled and treated with tibolone.
- Significant improvements were observed in overall sexual satisfaction.
- Key aspects of libido showed statistically significant enhancement following treatment.
Conclusions:
- Tibolone demonstrates positive effects on multiple dimensions of sexual life in postmenopausal women.
- Potential mechanisms include increased genital blood flow and combined central estrogenic/androgenic activity.
- Tibolone represents a beneficial therapeutic option for addressing menopausal sexual health concerns.